A detailed history of Horizon Financial Services, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Horizon Financial Services, LLC holds 45 shares of NVO stock, worth $2,180. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45
Previous 0 Infinity%
Holding current value
$2,180
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 12, 2026

BUY
$45.68 - $59.65 $2,055 - $2,684
45 New
45 $2,000
Q3 2025

Nov 12, 2025

SELL
$45.38 - $71.7 $363 - $573
-8 Closed
0 $0
Q1 2025

May 07, 2025

SELL
$69.3 - $90.95 $37,976 - $49,840
-548 Reduced 98.56%
8 $0
Q1 2025

Apr 28, 2025

BUY
$69.3 - $90.95 $37,976 - $49,840
548 Added 6850.0%
556 $8,000
Q1 2024

Apr 26, 2024

BUY
$102.11 - $135.92 $816 - $1,087
8 New
8 $1,000
Q1 2022

Apr 27, 2022

SELL
$93.1 - $112.54 $7,913 - $9,565
-85 Closed
0 $0
Q2 2021

Jul 22, 2021

BUY
$67.66 - $84.76 $5,751 - $7,204
85 New
85 $7,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Horizon Financial Services, LLC Portfolio

Follow Horizon Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Financial Services, LLC with notifications on news.